OR WAIT null SECS
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending December 3, 2022.
Holding methotrexate after the second COVID-19 vaccine dose is associated with similar immunogenicity and a lower risk of disease flare compared with withholding methotrexate after both vaccine doses.
New research from a team at the Karolinska Institutet suggests media coverage of studies examining cannabis use as a method for alleviating chronic pain are the recipients of a significant level of positive media coverage, regardless of results.
Identifying the current prevalence and effect of fatigue on patients with psoriatic arthritis may lead to new strategies designed to manage this commonly-reported symptom.
Investigators strive to learn more about whether mTORC1 inhibitors are a feasible approach for treating patients with systemic JIA.
In the wake of the Supreme Court’s decision to overturn Roe v Wade, results of a recent study indicated that more than half of female patients treated with methotrexate, a commonly-prescribed drug used to manage rheumatic diseases, lived in states with abortion restrictions or bans.